Neuropace Inc (NASDAQ:NPCE)
| 4.99 Delayed Data As of 3:59pm ET |  +0.04 / +0.81%Today’s Change | 4.61 Today|||52-Week Range 25.26 | -50.50% Year-to-Date |
Latest NPCE News | Press Releases
No recent news for Neuropace Inc.
Today’s Trading
| Previous close | 4.95 |
| Today’s open | 4.99 |
| Day’s range | 4.99 - 5.05 |
| Volume | 789 |
| Average volume (3 months) | 66,049 |
| Market cap | $132.4M |
Data as of 3:59pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | -44.81% |
| Earnings growth (this year) | +11.06% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +9.83% |
| P/E ratio | NM |
| Price/Sales | 5.46 |
| Price/Book | 1.70 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | -$0.45 |
| Annual revenue (last year) | $45.2M |
| Annual profit (last year) | -$36.1M |
| Net profit margin | -79.85% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters --, -- |
Forecasts
